Snijders MP - Search Results

1

Mifepristone and misoprostol versus misoprostol alone for uterine evacuation after early pregnancy failure: study protocol for a randomized double blinded placebo-controlled comparison (Triple M Trial).

van den Berg J, Hamel CC, Snijders MP, Coppus SF, Vandenbussche FP. van den Berg J, et al. Among authors: snijders mp. BMC Pregnancy Childbirth. 2019 Nov 27;19(1):443. doi: 10.1186/s12884-019-2497-y. BMC Pregnancy Childbirth. 2019. PMID: 31775677 Free PMC article.

2

Predicting the likelihood of successful medical treatment of early pregnancy loss: development and internal validation of a clinical prediction model.

Hamel CC, Vart P, Vandenbussche FPHA, Braat DDM, Snijders MPLM, Coppus SFPJ. Hamel CC, et al. Among authors: snijders mplm. Hum Reprod. 2022 May 3;37(5):936-946. doi: 10.1093/humrep/deac048. Hum Reprod. 2022. PMID: 35333346 Free PMC article. Clinical Trial.

3

Economic evaluation of a randomized controlled trial comparing mifepristone and misoprostol with misoprostol alone in the treatment of early pregnancy loss.

Hamel CC, Snijders MPLM, Coppus SFPJ, Vandenbussche FPHA, Braat DDM, Adang EMM. Hamel CC, et al. Among authors: snijders mplm. PLoS One. 2022 Feb 9;17(2):e0262894. doi: 10.1371/journal.pone.0262894. eCollection 2022. PLoS One. 2022. PMID: 35139105 Free PMC article. Clinical Trial.

4

Mifepristone followed by misoprostol compared with placebo followed by misoprostol as medical treatment for early pregnancy loss (the Triple M trial): A double-blind placebo-controlled randomised trial.

Hamel C, Coppus S, van den Berg J, Hink E, van Seeters J, van Kesteren P, Merién A, Torrenga B, van de Laar R, Terwisscha van Scheltinga J, Gaugler-Senden I, Graziosi P, van Rumste M, Nelissen E, Vandenbussche F, Snijders M. Hamel C, et al. EClinicalMedicine. 2021 Jan 6;32:100716. doi: 10.1016/j.eclinm.2020.100716. eCollection 2021 Feb. EClinicalMedicine. 2021. PMID: 33681738 Free PMC article.

5

Sequential use of mifepristone and misoprostol in treatment of early pregnancy failure appears more effective than misoprostol alone: a retrospective study.

van den Berg J, van den Bent JM, Snijders MP, de Heus R, Coppus SF, Vandenbussche FP. van den Berg J, et al. Among authors: snijders mp. Eur J Obstet Gynecol Reprod Biol. 2014 Dec;183:16-9. doi: 10.1016/j.ejogrb.2014.10.010. Epub 2014 Oct 14. Eur J Obstet Gynecol Reprod Biol. 2014. PMID: 25461345 Free article.

6

Current and future expectations of mifepristone treatment in early pregnancy failure: a survey among Dutch gynaecologists.

van den Berg J, Hamel CC, Coppus SF, Snijders MP, Vandenbussche FP. van den Berg J, et al. Among authors: snijders mp. J Obstet Gynaecol. 2019 Oct;39(7):1006-1011. doi: 10.1080/01443615.2019.1602598. Epub 2019 Jun 19. J Obstet Gynaecol. 2019. PMID: 31215270

7

Efficacy and tolerability of a new estradiol delivering matrix patch (Estraderm MX) in postmenopausal women.

de Vrijer B, Snijders MP, Troostwijk AL, Thé S, Iding RJ, Friese S, Smit DA, Schierbeek JM, Brandts H, van Kempen PJ, van Buuren I, Monza G. de Vrijer B, et al. Among authors: snijders mp. Maturitas. 2000 Jan 15;34(1):47-55. doi: 10.1016/s0378-5122(99)00085-7. Maturitas. 2000. PMID: 10687882 Clinical Trial.

8

Cyclophosphamide, epirubicin and cisplatin (CEP) versus epirubicin plus cisplatin (EP) in stage Ic-IV ovarian cancer: a randomized phase III trial of the Gynecologic Oncology Group of the Comprehensive Cancer Center Limburg.

Wils J, van Geuns H, Stoot J, Bergmans M, Boschma F, Bron H, Degen J, Erdkamp F, van Erp J, Haest J, Iding R, Lalisang F, de Pree N, de Rooy C, Snijders M, Schepers J, Vreeswijk J, Wals J, Werter M, Wetzels L, Smeets J, Schouten L. Wils J, et al. Anticancer Drugs. 1999 Mar;10(3):257-61. doi: 10.1097/00001813-199903000-00001. Anticancer Drugs. 1999. PMID: 10327029 Clinical Trial.

9

Outcomes of endometrial cancer prevention strategies in patients with Lynch syndrome: a nationwide cohort study in the Netherlands.

Eikenboom EL, van Leeuwen L, Groenendijk F, Woolderink JM, Van Altena AM, Van Leerdam ME, Spaander MCW, van Doorn HC, Wagner A; collaborative investigators from the Dutch Foundation for Detection of Hereditary Tumors. Eikenboom EL, et al. EClinicalMedicine. 2024 Dec 21;79:103006. doi: 10.1016/j.eclinm.2024.103006. eCollection 2025 Jan. EClinicalMedicine. 2024. PMID: 39816931 Free PMC article.

10

Hormonal biomarkers remain prognostically relevant within the molecular subgroups in endometrial cancer.

Vrede SW, Van Weelden WJ, Bulten J, Gilks CB, Teerenstra S, Huvila J, Matias-Guiu X, Gil-Moreno A, Asberger J, Sweegers S, van der Putten LJM, Küsters-Vandevelde HVN, Reijnen C, Colas E, Hausnerová J, Weinberger V, Snijders MPLM, Vinklerova P, Ravaggi A, Odicino F, Bignotti E, McAlpine JN, Kruitwagen R, Pijnenborg JMA. Vrede SW, et al. Among authors: snijders mplm. Gynecol Oncol. 2025 Jan;192:15-23. doi: 10.1016/j.ygyno.2024.10.028. Epub 2024 Nov 7. Gynecol Oncol. 2025. PMID: 39515079 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

60 results

Search Page

Filters